Outpatient Palliative Care Improves Parkinson Outcomes
Compared with standard care alone, outpatient palliative care is associated with benefits among patients with Parkinson disease and related disorders.
Parkinson’s Disease
PARKINSON DISEASE
Latest News
Infinity DBS System Gains Expanded Approval for Parkinson Disease Management
The FDA has approved an expanded indication for the Infinity™ Deep Brain Stimulation (DBS) system (Abbott) to include targeting the internal globus pallidus, which may lead to symptom improvement in patients with Parkinson disease.
In Parkinson Disease, Serious Adverse Events Tied to Nilotinib
Among patients with moderately severe Parkinson disease, exploratory biomarkers are altered in response to nilotinib, but the rate of serious adverse events (SAEs) is significantly higher in those receiving nilotinib versus placebo.
Inappropriate Antipsychotics Raise Pneumonia Risk in Older Adults With Parkinson Disease
Patients with Parkinson disease (PD) who use inappropriate antipsychotics may be at an increased risk for pneumonia compared with patients with PD who use more appropriate atypical antipsychotics.
Bipolar Disorder Associated With Increased Risk for Parkinson Disease
Published studies that included data on the risk for PD in patients with BD vs the general population without BD were included in a systematic review.
Nourianz Now Available for Patients With Parkinson Disease Experiencing “Off” Episodes
Nourianz is now available as an adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson disease (PD) experiencing “off” episodes.
FDA Cracks Down on Company Selling CBD Products With Unapproved Therapeutic Claims
The Food and Drug Administration (FDA) has issued a warning letter to Curalef Inc. of Wakefield, Massachusetts for illegally selling unapproved cannabidiol (CBD) products online with unsubstantiated health claims.
Suicidal Behavior Seen After Deep Brain Stimulation for Parkinson Disease
In patients with Parkinson disease who receive subthalamic nucleus deep brain stimulation, suicide behaviors tend to occur during the first 3 years after the procedure.
Recommendations for Screening and Rating Impulse Control Disorders in Parkinson Disease
International Parkinson’s and Movement Disorder Society released recommendations on clinical screening instruments and rating scales used to measure impulsive and compulsive behaviors in Parkinson disease.
Parkinson Disease Risk Increased in Bipolar Disorder
More frequent manic/mixed and depressive episodes were associated with an increased risk for Parkinson disease.
Want to read more?
Please login or register first to view this content.
Next post in Parkinson Disease
